SEC Form 4 · accession 0001209191-15-060997
TENET HEALTHCARE CORP · THC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Trevor Fetter
Officer — Chairman and CEO · Director
Period of report
Jul 13, 2015
Accepted (ET)
Jul 15, 2015 · 6:50 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000070318
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jul 13, 2015 | S | 300 | $60.067 | D | 804,649 | D | |
| Common Stock | Jul 13, 2015 | M | 87,704 | $31.72 | A | 892,353 | D | |
| Common StockF1,F3 | Jul 13, 2015 | S | 87,704 | $60.081 | D | 804,649 | D | |
| Common StockF1,F4 | Jul 14, 2015 | S | 56,997 | $60.242 | D | 747,652 | D | |
| Common Stock | Jul 14, 2015 | M | 39,480 | $31.72 | A | 787,132 | D | |
| Common StockF1,F5 | Jul 14, 2015 | S | 39,480 | $60.627 | D | 747,652 | D | |
| Common Stock | holding | — | — | — | 2,550 | I | By Spouse |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2006 February Option (Right to Buy)F6 | $31.72 | Jul 13, 2015 | M | 87,704 | D | — | Feb 22, 2016 | Common Stock | 87,704 | 39,480 | D |
| 2006 February Option (Right to Buy)F6 | $31.72 | Jul 14, 2015 | M | 39,480 | D | — | Feb 22, 2016 | Common Stock | 39,480 | 0 | D |
Explanation of responses
- F1These shares were sold in open market broker transactions pursuant to a Rule 10b5-1 trading plan.
- F2This transaction was executed in multiple trades at prices ranging from $60.00 to $60.10 per share. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3This transaction was executed in multiple trades at prices ranging from $60.00 to $60.23 per share. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4This transaction was executed in multiple trades at prices ranging from $60.00 to $60.75 per share. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5This transaction was executed in multiple trades at prices ranging from $60.00 to $60.92 per share. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6These stock options vested and became exercisable in one-third increments on each of the first, second and third anniversaries of the date of grant.